⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30978583 | 1.00 | — | — | |
| SCHEMBL26077289 | 1.00 | — | — | |
| SCHEMBL15369748 | 1.00 | — | — | |
| SCHEMBL301135 | 0.94 | POLB (0.52) | — | |
| SCHEMBL3984121 | 0.94 | POLB (0.52) | — | |
| SCHEMBL25467330 | 0.94 | POLB (0.52) | — | |
| SCHEMBL18419252 | 0.94 | POLB (0.52) | — | |
| SCHEMBL301620 | 0.91 | POLB (0.50) | — | |
| SCHEMBL5806994 | 0.91 | POLB (0.50) | — | |
| SCHEMBL9132022 | 0.91 | POLB (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022114135-A1 | CRYSTAL FORM OF AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAME | 大正製薬株式会社 | 2022-06-02 | — | — | WO | claimed |
| CN-109071418-B | Prodrugs of amino acid derivatives | 大正制药株式会社 | 2022-03-18 | — | — | CN | claimed |
| EP-1562575-B1 | FUSED CYCLOALKYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS FOR THE TREATMENT OF I.A. EPILEPSY | ABBOTT LAB (US) | 2009-05-20 | — | — | EP | claimed |
| EP-1164121-B1 | NOVEL CARBOXYLIC ACID DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | TAISHO PHARMACEUTICAL CO LTD (JP) | 2008-10-29 | — | — | EP | claimed |
| EP-1562575-A1 | FUSED CYCLOALKYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS FOR THE TREATMENT OF I.A. EPILEPSY | Abbott Laboratories (US) | 2005-08-17 | — | — | EP | claimed |
| US-20040209859-A1 | Fused cycloalkyl amides and acids and their therapeutic applications | ABBOTT LABORATORIES | 2004-10-21 | — | — | US | claimed |
| WO-2004037241-A1 | FUSED CYCLOALKYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS FOR THE TREATMENT OF I.A. EPILEPSY | ABBOTT LABORATORIES (US) | 2004-05-06 | — | — | WO | claimed |
| US-20040077617-A1 | Fused cycloalkyl amides and acids and their therapeutic applications | ABBOTT LABORATORIES | 2004-04-22 | — | — | US | claimed |
| US-6500958-B2 | PSYCHOLOGICAL DISORDERS; BRAIN DISORDERS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-12-31 | — | — | US | claimed |
| US-20020156299-A1 | NOVEL CARBOXYLIC ACID DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | TAISHO PHARMACEUTICAL CO., LTD. | 2002-10-24 | — | — | US | claimed |
| EP-1164121-A1 | NOVEL CARBOXYLIC ACID DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2001-12-19 | — | — | EP | claimed |
| US-12435057-B2 | Triazole carboxylic acids as LPA antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-10-07 | — | — | US | disclosed |
| US-12384768-B2 | Isoxazole carboxylic acids as LPA antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-12 | — | — | US | disclosed |
| EP-4594309-A1 | AZOLE MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION | Genentech Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-115073394-B | High allyl compound and preparation method and application thereof | 上海中医药大学 | 2024-12-06 | — | — | CN | disclosed |
| US-6500958-B2 | PSYCHOLOGICAL DISORDERS; BRAIN DISORDERS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-12-31 | — | — | US | disclosed |
| US-6479674-B1 | Carboxylic acid derivatives and process for producing same | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-11-12 | — | — | US | disclosed |
| US-20020156299-A1 | NOVEL CARBOXYLIC ACID DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | TAISHO PHARMACEUTICAL CO., LTD. | 2002-10-24 | — | — | US | disclosed |
| EP-1164121-A1 | NOVEL CARBOXYLIC ACID DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2001-12-19 | — | — | EP | disclosed |
| CN-1207678-A | Excitatory amino acid receptor antagonists | LILLY CO ELI (US) | 1999-02-10 | — | — | CN | disclosed |